Small molecule NSAID derivatives for impairing powerhouse in cancer cells

Area of Science:

• Mitochondrial biology
• Cancer therapeutics
• Medicinal chemistry

Background:

• Mitochondria play a crucial role in cancer progression.
• Targeting mitochondria is a promising anti-cancer strategy.
• Developing selective small molecules for mitochondria remains challenging.

Purpose of the Study:

• To synthesize novel small molecules for mitochondria localization.
• To investigate the anti-cancer potential of NSAID-phosphonium hybrids.
• To explore mitochondria-targeted drug delivery for cancer therapy.

Main Methods:

• Concise synthesis of indomethacin and ibuprofen derivatives with triarylphosphonium moiety.
• Mitochondrial localization studies.
• Assessment of mitochondrial damage, reactive oxygen species (ROS) generation, and apoptosis induction in MCF7 breast cancer cells.

Main Results:

• Successful synthesis of a small molecule library of NSAID derivatives with mitochondria-targeting phosphonium groups.
• Identification of two compounds inducing mitochondrial outer membrane permeabilization (MOMP).
• Demonstrated ROS generation and apoptosis-mediated cell death in MCF7 cells, highlighting anti-cancer efficacy.

Conclusions:

• Novel mitochondria-targeted NSAID derivatives show significant anti-cancer activity.
• These compounds induce cancer cell death via MOMP and ROS generation.
• This approach offers a new direction for developing mitochondria-based anti-cancer drugs.